Rakuten Securities’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.7K Buy
416
+1
+0.2% +$94 0.01% 299
2026
Q1
$36.9K Buy
415
+28
+7% +$2.88K 0.02% 277
2025
Q4
$36.8K Sell
387
-656
-63% -$66.1K 0.01% 272
2025
Q3
$103K Buy
1,043
+681
+188% +$72.8K 0.04% 188
2025
Q2
$38.5K Buy
362
+82
+29% +$8.28K 0.02% 250
2025
Q1
$25.5K Sell
280
-40
-13% -$4.48K 0.01% 284
2024
Q4
$36.5K Buy
320
+35
+12% +$3.99K 0.01% 235
2024
Q3
$33.8K Sell
285
-118
-29% -$10.8K 0.01% 216
2024
Q2
$32.4K Sell
403
-1,579
-80% -$144K 0.01% 212
2024
Q1
$183K Buy
1,982
+711
+56% +$68.2K 0.08% 97
2023
Q4
$134K Buy
+1,271
New +$128K 0.11% 109

Other funds holding BNTX

Rakuten Securities's BNTX Position: Q2 2026 in Review

Rakuten Securities increased its BioNTech (BNTX) stake by 0.24% in Q2 2026, buying an estimated $94 and bringing the position to 416 shares worth $38.7K. The position accounts for 0.01% of the portfolio, ranked #299.

Rakuten Securities first reported a position in BNTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $183K in Q1 2024. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Rakuten Securities held 416 shares of BioNTech worth $38.7K as of Q2 2026.
  • Rakuten Securities bought 1 BioNTech share in Q2 2026, an estimated $94.
  • BioNTech made up 0.01% of Rakuten Securities's portfolio in Q2 2026, its #299 holding.
  • Rakuten Securities first reported a position in BioNTech in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's BioNTech position peaked at $183K in Q1 2024.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.